Atlas Trials

Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence

Clinical trial NCT00123773 · COMPLETED

Trial details

NCT number
NCT00123773
Sponsor
AHS Cancer Control Alberta
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
SarcomaMultiple MyelomaTesticular NeoplasmsOvarian NeoplasmsKidney Neoplasms
Start date
2004-04-01
Primary completion
2008-12-01
Enrollment
1075

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.